3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
5
Other hematologic neoplasm
2
Lymphoid
2
Other neoplasm
1
Genitourinary
1
Conditions
Precancerous Conditions
1
Neoplasms
1
Keratosis, Actinic
1
Keratosis
1
Interventions
Biopsy
8
Polymerase Chain Reaction
6
Peripheral Blood Stem Cell Transplantation
5
Epoetin Alfa
5
Surveys and Questionnaires
4
Sulindac
4
Microarray Analysis
4
Gene Expression Profiling
4
Early Intervention, Educational
4
Cyclophosphamide
4
Colposcopy
4
Cisplatin
4
Cetuximab
4
Celecoxib
4
fludarabine phosphate
3
Vaginal Smears
3
Selenium
3
Pemetrexed
3
Methotrexate
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Eflornithine
3
Darbepoetin alfa
3
Aspirin
3
Antilymphocyte Serum
3
Whole-Body Irradiation
2
Vitamin E
2
Videotape Recording
2
Tacrolimus
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
tirbanibulin
×
Other neoplasm
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled